Article: Omnaris nasal spray.(New & Approved)(Drug overview)

Omnaris Nasal Spray (ciclesonide nasal spray, Nycomed) The FDA approved Omnaris (ciclesonide) Nasal Spray for treatment of seasonal allergic rhinitis in patients aged 6-11 years.

* Recommended Dosage: The recommended 200 mcg per day is delivered as two sprays (50 mcg per spray) in each nostril once daily for treatment of seasonal allergic rhinitis in adults and children 6 years of age and older.

* Special Considerations: Headache, nasopharyngitis, and pharyngolaryngeal pain were the most common adverse events associated with Omnaris Nasal Spray in a study of patients aged 6-11 years.

Patients who are on immunosuppressive doses of corticosteroids ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!